Bibliography

References

2014

187.
Kielstein, J. T.

[Drug dosing in extracorporeal therapy]

Med Klin Intensivmed Notfmed, 109(5):348-53 2014 ISSN: 2193-6226 (Electronic) 2193-6218 (Linking)DOI: 10.1007/s00063-014-0349-0
 
186.
Kielstein, J. T.; Bernstein, H. G.

The reversible part of cognitive impairment in chronic kidney disease: can mice help men break the TEMPOLimit?

Nephrol Dial Transplant, 29(3):476-8 2014 ISSN: 1460-2385 (Electronic) 0931-0509 (Linking)DOI: 10.1093/ndt/gft403
 
185.
Kleimann, A., Toto, S., Eberlein, C. K., Kielstein, J. T., Bleich, S., Frieling, H.; Sieberer, M.

Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome

PLoS One, 9(7):e101839 2014 ISSN: 1932-6203 (Electronic) 1932-6203 (Linking)DOI: 10.1371/journal.pone.0101839
 
184.
Lavergne, V., Ouellet, G., Bouchard, J., Galvao, T., Kielstein, J. T., Roberts, D. M., Kanji, S., Mowry, J. B., Calello, D. P., Hoffman, R. S., Gosselin, S., Nolin, T. D., Goldfarb, D. S., Burdmann, E. A., Dargan, P. I., Decker, B. S., Hoegberg, L. C., Maclaren, R., Megarbane, B., Sowinski, K. M., Yates, C., Mactier, R., Wiegand, T.; Ghannoum, M.

Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology

Semin Dial, 27(4):407-14 2014 ISSN: 1525-139X (Electronic) 0894-0959 (Linking)DOI: 10.1111/sdi.12251
 
183.
Lukasz, A., Beneke, J., Menne, J., Vetter, F., Schmidt, B. M., Schiffer, M., Haller, H., Kumpers, P.; Kielstein, J. T.

Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS)

Thromb Haemost, 111(2):365-72 2014 ISSN: 0340-6245 (Print) 0340-6245 (Linking)DOI: 10.1160/TH13-05-0387
 
182.
Lukasz, A., Hoffmeister, B., Graf, B., Wolk, B., Noeckler, K., Bode-Boger, S. M., Hadem, J., Pischke, S.; Kielstein, J. T.

Association of angiopoietin-2 and dimethylarginines with complicated course in patients with leptospirosis

PLoS One, 9(1):e87490 2014 ISSN: 1932-6203 (Electronic) 1932-6203 (Linking)DOI: 10.1371/journal.pone.0087490
 
181.
Molnar, M. Z., Kumpers, P., Kielstein, J. T., Schiffer, M., Czira, M. E., Ujszaszi, A., Kovesdy, C. P.; Mucsi, I.

Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study

Transpl Int, 27(6):541-52 2014 ISSN: 1432-2277 (Electronic) 0934-0874 (Linking)DOI: 10.1111/tri.12293
 
180.
Schepers, E., Speer, T., Bode-Boger, S. M., Fliser, D.; Kielstein, J. T.

Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?

Semin Nephrol, 34(2):97-105 2014 ISSN: 1558-4488 (Electronic) 0270-9295 (Linking)DOI: 10.1016/j.semnephrol.2014.02.003
 
179.
Schmidt, J. J., Hafer, C., Spielmann, J., Hadem, J., Schonenberger, E., Schmidt, B. M.; Kielstein, J. T.

Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis

Nephron Clin Pract, 126(1):62-6 2014 ISSN: 1660-2110 (Electronic) 1660-2110 (Linking)DOI: 10.1159/000358434
 
178.
Schmidt, J. J., Lorenzen, J., Chatzikyrkou, C., Lichtinghagen, R.; Kielstein, J. T.

Total collected dialysate lithium concentration after successful dialysis treatment in case of intoxication

BMC Pharmacol Toxicol, 15:49 2014 ISSN: 2050-6511 (Electronic) 2050-6511 (Linking)DOI: 10.1186/2050-6511-15-49
 
177.
Strunk, A. K., Schmidt, J. J., Baroke, E., Bode-Boger, S. M., Martens-Lobenhoffer, J., Welte, T.; Kielstein, J. T.

Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis

J Antimicrob Chemother, 69(7):2008-10 2014 ISSN: 1460-2091 (Electronic) 0305-7453 (Linking)DOI: 10.1093/jac/dku075
 

2013

176.
Bertram, A., Haenel, S. S., Hadem, J., Hoeper, M. M., Gottlieb, J., Warnecke, G., Kaschinski, S., Hafer, C., Kuhn-Velten, W. N., Gunther, D.; Kielstein, J. T.

Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy

BMC Pharmacol Toxicol, 14:45 2013 ISSN: 2050-6511 (Electronic) 2050-6511 (Linking)DOI: 10.1186/2050-6511-14-45
 
Page:  
Previous|1, ... , 3, 4, 5, 6, 7, ... , 20|Next
Export as:
BibTeX, XML